BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10767245)

  • 1. Oral absorption of clarithromycin in acute illness and during convalescence in patients with community-acquired pneumonia.
    Offman E; Varin F; Nolan T; Bayliff CD; Bombassaro AM; McCormack DG
    Chest; 2000 Apr; 117(4):1090-3. PubMed ID: 10767245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarithromycin bioequivalence study of two oral formulations in healthy human volunteers.
    Lerner FE; Caliendo G; Santagada V; Santana GSM ; Moraes MEA ; De Nucci G
    Int J Clin Pharmacol Ther; 2000 Jul; 38(7):345-54. PubMed ID: 10919343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bioavailability of clarithromycin formulations in healthy brazilian volunteers.
    Ruenis AP; Moreno RA; Abib-Júnior E; Simões RP; Franco LM; Groppo FC; Baglie S; Franco GC; Rosalen PL
    Int J Clin Pharmacol Ther; 2005 Aug; 43(8):399-404. PubMed ID: 16119515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The steady-state disposition of indinavir is not altered by the concomitant administration of clarithromycin.
    Boruchoff SE; Sturgill MG; Grasing KW; Seibold JR; McCrea J; Winchell GA; Kusma SE; Deutsch PJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):351-9. PubMed ID: 10801243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.
    Rodvold KA; Gotfried MH; Danziger LH; Servi RJ
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1399-402. PubMed ID: 9174209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy of oral clarithromycin monotherapy in patients with mild or moderate community-acquired pneumonia].
    Fujiki R; Rikimaru T; Aizawa H; Kawayama T
    Jpn J Antibiot; 2003 Dec; 56(6):712-8. PubMed ID: 15007880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
    Rengelshausen J; Göggelmann C; Burhenne J; Riedel KD; Ludwig J; Weiss J; Mikus G; Walter-Sack I; Haefeli WE
    Br J Clin Pharmacol; 2003 Jul; 56(1):32-8. PubMed ID: 12848773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin.
    Niederman MS; Chang JR; Stewart J; Nusrat R; Nieman RB
    Curr Med Res Opin; 2004 May; 20(5):749-56. PubMed ID: 15140342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae.
    Noreddin AM; El-Khatib WF; Aolie J; Salem AH; Zhanel GG
    Int J Infect Dis; 2009 Jul; 13(4):483-7. PubMed ID: 19046911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interaction between ritonavir and clarithromycin.
    Ouellet D; Hsu A; Granneman GR; Carlson G; Cavanaugh J; Guenther H; Leonard JM
    Clin Pharmacol Ther; 1998 Oct; 64(4):355-62. PubMed ID: 9797791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days.
    Tellier G; Chang JR; Asche CV; Lavin B; Stewart J; Sullivan SD
    Curr Med Res Opin; 2004 May; 20(5):739-47. PubMed ID: 15140341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral cimetidine prolongs clarithromycin absorption.
    Amsden GW; Cheng KL; Peloquin CA; Nafziger AN
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1578-80. PubMed ID: 9660986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials.
    Niederman MS; Chang JR; Stewart J; Asche CV; Lavin B; Nusrat R; Sullivan SD
    Curr Med Res Opin; 2004 Jul; 20(7):969-80. PubMed ID: 15265241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
    Tamm M; Todisco T; Feldman C; Garbino J; Blasi F; Hogan P; de Caprariis PJ; Hoepelman IM
    Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
    Querol-Ribelles JM; Tenías JM; Querol-Borrás JM; Labrador T; Nieto A; González-Granda D; Martínez I
    Int J Antimicrob Agents; 2005 Jan; 25(1):75-83. PubMed ID: 15620830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of clarithromycin into middle ear fluid of children with acute otitis media.
    Gan VN; McCarty JM; Chu SY; Carr R
    Pediatr Infect Dis J; 1997 Jan; 16(1):39-43. PubMed ID: 9002099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care.
    Dean NC; Sperry P; Wikler M; Suchyta MS; Hadlock C
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1164-9. PubMed ID: 16569825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clarithromycin pharmacokinetics in healthy young and elderly volunteers.
    Chu SY; Wilson DS; Guay DR; Craft C
    J Clin Pharmacol; 1992 Nov; 32(11):1045-9. PubMed ID: 1474166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis.
    Yoshida K; Okimoto N; Kishimoto M; Fukano H; Hara H; Yoneyama H; Moriya O; Kawanishi M; Kimura M; Matsushima T; Niki Y
    J Infect Chemother; 2011 Oct; 17(5):678-85. PubMed ID: 21847518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.